Key facts
- This page summarizes Mithril LP's Form 4 filing for Fractyl Health, Inc. (GUTS).
- 8 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 08 Feb 2024, 16:35.
Mithril LP - 06 Feb 2024 Form 4 Insider Report for Fractyl Health, Inc. (GUTS)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- GUTS
- Reported as of
- 06 Feb 2024
- Net transaction value
- +$4,999,995
- SEC form
- 4
- Accepted by SEC
- 08 Feb 2024, 16:35:00 UTC
- Prior SEC filing
- 01 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- Mithril II UGP LLC By: /s/ Ajay Royan, Managing Member
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mithril LP filed Form 4 for Fractyl Health, Inc. (GUTS) on 08 Feb 2024.
Change
- Previous filing in this sequence was filed on 01 Feb 2024.
- Current net transaction value: +$4,999,995.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GUTS
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +5,160,301
- Change %
- Price
- Shares after
- 5,160,301
- Date
- 06 Feb 2024
- Ownership
- Direct
- Footnotes
- F1, F2
GUTS
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +918,567
- Change %
- Price
- Shares after
- 918,567
- Date
- 06 Feb 2024
- Ownership
- See footnote
- Footnotes
- F1, F3
GUTS
transaction
Common Stock
Purchase
- Transaction value
- $4,999,995
- Shares
- +333,333
- Change %
- +36%
- Price
- $15.00*
- Shares after
- 1,251,900
- Date
- 06 Feb 2024
- Ownership
- See footnote
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GUTS
transaction
Derivative
Series C-1 Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -4,025,764
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 06 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,875,938
- Exercise price
- Footnotes
- F1, F2
GUTS
transaction
Derivative
Series C-2 Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -6,502,796
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 06 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,030,193
- Exercise price
- Footnotes
- F1, F2
GUTS
transaction
Derivative
Series D Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -545,450
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 06 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 254,170
- Exercise price
- Footnotes
- F1, F2
GUTS
transaction
Derivative
Series E Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -373,021
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 06 Feb 2024
- Ownership
- See footnote
- Underlying class
- Common Stock
- Underlying amount
- 173,821
- Exercise price
- Footnotes
- F1, F3
GUTS
transaction
Derivative
Series F Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -1,598,225
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 06 Feb 2024
- Ownership
- See footnote
- Underlying class
- Common Stock
- Underlying amount
- 744,746
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock.
Footnote F2
Represents securities held by Mithril LP ("LP"). Mithril GP LP ("GP LP") is the general partner of LP and may be deemed to have shared voting and dispositive power with respect to the securities held by LP. Ajay Royan, a member of the Issuer's board of directors, is the authorized person of GP LP. Mr. Royan and Peter Thiel are the members of the investment committee of GP LP, and in such capacities may be deemed to have beneficial ownership of the securities held by LP. Each of GP LP and Mr. Thiel disclaims such beneficial ownership except to the extent of its and his respective pecuniary interest therein, if any. Mr. Royan is a director of the Issuer and files separate Section 16 reports.
Footnote F3
Represents securities held by Mithril II LP ("II LP"). Mithril II UGP LLC ("UGP II") is the general partner of Mithril II GP LP ("GP II"), which is the general partner of II LP, and each of UGP II and GP II may be deemed to have shared voting and dispositive power with respect to the securities held by II LP. Mr. Royan is the sole managing member of UGP II. Messrs. Royan and Thiel are the members of the investment committee of GP II, and in such capacities may be deemed to have beneficial ownership of the securities held by II LP. Each of UGP II, GP II and Mr. Thiel disclaims such beneficial ownership except to the extent of its and his respective pecuniary interest therein, if any. Mr. Royan is a director of the Issuer and files separate Section 16 reports.